Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-05

Clinical Trial Update: NHFOV Versus NCPAP to Prevent Exubation Failure [NA]

View source ↗

Summary

A clinical trial comparing NHFOV to NCPAP to prevent extubation failure in respiratory distress syndrome has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Manitoba | Conditions: Respiratory Distress Syndrome | NA | Status: SUSPENDED